Stimulation of Multiple Organoids Simultaneously

Project Information

STIMOS

Grant agreement ID: 842804

DOI 10.3030/842804

Project closed

EC signature date 12 April 2019

Start date 2 September 2019

End date 1 September 2021

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 203 149,44

EU contribution € 203 149,44

Coordinated by

MAXWELL BIOSYSTEMS AG
Switzerland

Objective

This project aims to develop STIMOS, an in-vitro platform to
simultaneously stimulate and record from multiple mouse or human
derived 3D retinal organoids by high-density multi electrode arrays.

Fields of science

• medical and health sciences › medical biotechnology

Keywords

• Retina electrophysiology
• multielectrode arrays technology
• visual restoration
• retinal ganglion cells
• axons
• mouse induced pluripotent stem cell-derived organoids

Programme(s)

• H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme
• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Topic(s)

• MSCA-IF-2018 - Individual Fellowships

Call for proposal

H2020-MSCA-IF-2018

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

Coordinator

MAXWELL BIOSYSTEMS AG

• Net EU contribution: € 203 149,44
• Address: ALBISRIEDERSTRASSE 253 ; 8047 Zurich ; Switzerland
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Schweiz/Suisse/Svizzera › Zürich › Zürich
• Region: Schweiz/Suisse/Svizzera › Zürich › Zürich
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 203 149,44